Company Profile
Fresenius Kabi Austria (Linz), a subsidiary of Fresenius AG (Germany), is one of the biggest producers of Lactulose. Following our principle ""Responsibility creates Trust"", we offer our high quality product worldwide in bulk form and as finished product (Trademark Laevolac (r)). The main indications of Lactulose are chronic constipation, disturbances of the intestinal flora and chronic liver disease. It activates the physiological reactions in the colon without producing any harmful or toxic effects on the organism.
